Disease | down syndrome |
Comorbidity | C0002395|alzheimer disease |
Sentences | 5 |
PubMedID- 22410580 | alzheimer disease: treatment of alzheimer disease in down syndrome. |
PubMedID- 23400708 | Apoe4 is a major genetic risk factor for alzheimer disease and is associated with dementia in down syndrome and poor neurological outcome after traumatic brain injury, cerebral hemorrhage, and other neuropathological disorders. |
PubMedID- 24558640 | We propose that sleep disruption is a lever arm that influences how cognition emerges in development and then declines in response to alzheimer disease in people with down syndrome. |
PubMedID- 22084131 | Conclusions: florbetapir pet can be used to detect increased cerebral-to-cerebellar fibrillar abeta burden in a down syndrome patient with alzheimer disease, even in the presence of frequent amyloid angiopathy and diffuse plaques in the cerebellum. |
PubMedID- 26243569 | Further study of the mechanisms underlying the development of alzheimer disease in people with down syndrome could provide insights into the mechanisms that cause dementia in the general population. |
Page: 1